News

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and nutrition.
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...
The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...